Mattias Berglund
Researcher at Department of Immunology, Genetics and Pathology; Research programme: Cancer Immunotherapy; Research group Gunilla Enblad
- E-mail:
- mattias.berglund@igp.uu.se
- Visiting address:
- Dag Hammarskjölds väg 20
SE-75185 Uppsala
Sweden - Postal address:
- Rudbecklaboratoriet
SE-75185 Uppsala
Sweden
Publications
Recent publications
Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
Part of Cell Reports Medicine, 2025
- DOI for Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
- Download full text (pdf) of Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
Part of Leukemia, p. 438-441, 2024
- DOI for Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
- Download full text (pdf) of Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
ADAR1-mediated RNA editing promotes B cell lymphomagenesis
Part of iScience, 2023
- DOI for ADAR1-mediated RNA editing promotes B cell lymphomagenesis
- Download full text (pdf) of ADAR1-mediated RNA editing promotes B cell lymphomagenesis
Part of Genes, Chromosomes and Cancer, p. 27-36, 2022
- DOI for Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
- Download full text (pdf) of Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
The dual role of CD70 in B‐cell lymphomagenesis
Part of Clinical and Translational Medicine, 2022
- DOI for The dual role of CD70 in B‐cell lymphomagenesis
- Download full text (pdf) of The dual role of CD70 in B‐cell lymphomagenesis
All publications
Articles in journal
Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
Part of Cell Reports Medicine, 2025
- DOI for Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
- Download full text (pdf) of Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphoma
Part of Leukemia, p. 438-441, 2024
- DOI for Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
- Download full text (pdf) of Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis
ADAR1-mediated RNA editing promotes B cell lymphomagenesis
Part of iScience, 2023
- DOI for ADAR1-mediated RNA editing promotes B cell lymphomagenesis
- Download full text (pdf) of ADAR1-mediated RNA editing promotes B cell lymphomagenesis
Part of Genes, Chromosomes and Cancer, p. 27-36, 2022
- DOI for Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
- Download full text (pdf) of Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology
The dual role of CD70 in B‐cell lymphomagenesis
Part of Clinical and Translational Medicine, 2022
- DOI for The dual role of CD70 in B‐cell lymphomagenesis
- Download full text (pdf) of The dual role of CD70 in B‐cell lymphomagenesis
Part of Acta Oncologica, p. 531-538, 2021
- DOI for PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
- Download full text (pdf) of PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS
Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
Part of Haematologica, p. 2502-2506, 2021
- DOI for Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
- Download full text (pdf) of Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma
Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival
Part of eJHaem, p. 199-207, 2020
- DOI for Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival
- Download full text (pdf) of Marginal zone lymphoma expression of histidine-rich glycoprotein correlates with improved survival
Part of Acta Oncologica, p. 106-109, 2017
Expression of possible targets for new proteasome inhibitors in diffuse large B-cell lymphoma
Part of European Journal of Haematology, p. 52-56, 2017
Chromosome 11q23 aberrations activating FOXR1 in B-cell lymphoma
Part of Blood Cancer Journal, 2016
- DOI for Chromosome 11q23 aberrations activating FOXR1 in B-cell lymphoma
- Download full text (pdf) of Chromosome 11q23 aberrations activating FOXR1 in B-cell lymphoma
Diffuse Large B Cell Lymphoma Cell Line U2946: Model for MCL1 Inhibitor Testing
Part of PLOS ONE, 2016
- DOI for Diffuse Large B Cell Lymphoma Cell Line U2946: Model for MCL1 Inhibitor Testing
- Download full text (pdf) of Diffuse Large B Cell Lymphoma Cell Line U2946: Model for MCL1 Inhibitor Testing
Part of Acta Oncologica, p. 1126-1131, 2016
Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cells
Part of Medical Oncology, 2015
Part of Acta Oncologica, p. 924-932, 2015
FOXR1 Activation in B-Cell Lymphoma
Part of Blood, 2015
Amplification of 2p as a Genomic Marker for Transformation in Lymphoma
Part of Genes, Chromosomes and Cancer, p. 750-768, 2014
- DOI for Amplification of 2p as a Genomic Marker for Transformation in Lymphoma
- Download full text (pdf) of Amplification of 2p as a Genomic Marker for Transformation in Lymphoma
Part of European Journal of Haematology, p. 500-508, 2014
U-2932: two clones in one cell line, a tool for the study of clonal evolution
Part of Leukemia, p. 1155-1164, 2013
Part of International Journal of Hematology, p. 465-471, 2013
DNA repair genes are selectively mutated in diffuse large B cell lymphomas
Part of Journal of Experimental Medicine, p. 1729-1742, 2013
Part of American Journal of Human Genetics, p. 167-172, 2013
High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma
Part of Oncology Reports, p. 720-724, 2013
Part of Haematologica, 2012
Part of Journal of Experimental Medicine, p. 291-305, 2012
Molecular Studies of Mechanisms of Drug Resistance in Malignant Cells With Focus on Lymphomas
Part of European Journal of Cancer, 2012
Part of Leukemia Research, p. 438-443, 2011
Is a TNF Alpha Polymorphism Responsible for Mutations in the TP53 Gene?
Part of Scandinavian Journal of Immunology, p. 154-155, 2011
Part of The Pharmacogenomics Journal, p. 61-71, 2011
Part of Blood, p. 4489-4489, 2011
Part of American Journal of Hematology, p. 418-425, 2010
Part of Leukemia and Lymphoma, p. 1563-1566, 2010
Part of Leukemia Research, p. 60-66, 2009
Part of Leukemia and Lymphoma, p. 1723-1725, 2009
Folate-metabolizing genes in lymphoma patients from Sweden
Part of Scandinavian Journal of Immunology, p. 408-410, 2009
Part of American Journal of Hematology, p. 803-808, 2009
Part of British Journal of Haematology, p. 683-684, 2009
Part of British Journal of Haematology, p. 423-32, 2008
Part of Leukemia and Lymphoma, p. 477-487, 2008
Genomic imbalances during transformation from follicular lymphoma to diffuse large B-cell lymphoma
Part of Modern Pathology, p. 63-75, 2007
Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas
Part of European Journal of Haematology, p. 283-289, 2007
Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma
Part of British Journal of Haematology, p. 68-71, 2007
Establishment of a cell line from a chemotherapy resistant diffuse large B-cell lymphoma
Part of Leukemia and Lymphoma, p. 1038-1041, 2007
Part of Blood, p. 4930-4935, 2007
CD40 expression identifies a prognostically favourable subgroup of diffuse large B-cell lymphoma
Part of Leukemia and Lymphoma, p. 1774-1779, 2007
Part of Leukemia and Lymphoma, p. 2221-2232, 2007
Part of Int J Cancer, p. 555-63, 2006
Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosis.
Part of Mod Pathol, p. 1113-20, 2005
Part of Blood, p. 4894-5; author reply 4895, 2005
Part of Leukemia and Lymphoma, p. 2179-2189, 2002
Articles, review/survey
Part of International Journal of Hematologic Oncology, p. 391-396, 2013